Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. - Dixon,W.G.; Watson,K.; Lunt,M. (Arthritis Rheum, 2006)